Celanese Corporation
NYSE:CEChemicals
-$0.24 today
- Market cap
- $5.29B
- Beta
- 0.74
- P/E (TTM)
- -5.1
- EPS (TTM)
- -$9.98
- Dividend yield
- 0.24%
Volume 1.38M
Average 2.09M
CE EBITDA Margin
EBITDA as a percentage of revenue.
Celanese CorporationNYSE: CE
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin narrows to 17.6%
EBITDA Margin was 17.6% in Q2 FY2026, down 2.4 pp from a year earlier. On a trailing-twelve-month basis it was 4.0%, up 1.4 pp year over year. Over 3 fiscal years it narrowed by 20.3 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 12 analysts of 23.1% for the fiscal year ending Dec 2026, up from 3.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 17.6%-2.7 pp QoQ
- Last fiscal yearDec 2025
- 3.5%-1.4 pp YoY
- LTMJun 2026
- 4.0%+1.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -2.4 pp | +64.8 pp | +67.2 pp |
| 1 year | -1.4 pp | +19.6 pp | +20.9 pp |
| 3 years | -20.3 pp | +19.5 pp | +39.8 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 3.5%
- Year-over-year change
- -1.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.5% | -1.4pp |
| FY2024 | 2024-12-31 | 4.9% | -19.0pp |
| FY2023 | 2023-12-31 | 23.9% | +0.1pp |
| FY2022 | 2022-12-31 | 23.8% | -8.0pp |
| FY2021 | 2021-12-31 | 31.8% | — |
EBITDA Margin vs competitors
How CE compares with its peers on the latest reported figures
- CE's LTM Jun 2026 EBITDA Margin of 4.0% is the lowest of the 10 companies compared; the peer median is 20.6%.
- Its year-over-year change of +1.4 pp is the 5th highest of 10, against a peer median of +1.3 pp.
- Over three fiscal years its change of -20.3 pp compares with a peer median of +2.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 52.0% | +13.7 pp | -11.4 pp | |
| LTM Jun 2026 | 48.6% | +21.8 pp | +2.2 pp | |
| FY2026 | 25.9% | +11.6 pp | +2.5 pp | |
| LTM Sep 2026 | 24.8% | +0.2 pp | +3.8 pp | |
| LTM Jun 2026 | 20.6% | +47.2 pp | -49.2 pp | |
| LTM Jun 2026 | 19.0% | -2.3 pp | +9.0 pp | |
| LTM Jun 2026 | 17.7% | +0.9 pp | -0.7 pp | |
| LTM Sep 2026 | 16.1% | -0.0 pp | +3.9 pp | |
| LTM Aug 2026 | 15.2% | +1.3 pp | +2.1 pp | |
| LTM Jun 2026 | 4.0% | +1.4 pp | -20.3 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding CE) | 20.6% | +1.3 pp | +2.2 pp | |
Competitors are the stored peer set for CE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 8.54B | 9.67B | 10.94B | 10.28B | 9.54B |
| Cost of Revenue | 5.86B | 7.29B | 8.34B | 7.92B | 7.75B |
| Gross Profit | 2.68B | 2.38B | 2.6B | 2.36B | 1.79B |
| Gross Margin | 31.4% | 24.6% | 23.8% | 22.9% | 18.8% |
| Research & Development | 86M | 112M | 146M | 130M | 125M |
| Selling, General & Admin | 633M | 824M | 1.08B | 1.03B | 899M |
| Operating Expenses | 736M | 1B | 916M | 3.05B | 1.02B |
| Depreciation & Amortization | 378M | 478M | 711M | 823M | 786M |
| EBITDA | 2.72B | 2.3B | 2.61B | 503M | 335M |
| EBITDA Margin | 31.8% | 23.8% | 23.9% | 4.9% | 3.5% |
| Operating Income | 1.95B | 1.38B | 1.69B | (697M) | 767M |
| Operating Margin | 22.8% | 14.2% | 15.4% | -6.8% | 8.0% |
| Interest Income | 8M | 69M | 39M | 33M | 24M |
| Interest Expense | 100M | 405M | 720M | 676M | 769M |
| Other Income / Expenses | 302M | 43M | (504M) | (299M) | (1.99B) |
| Income Before Tax | 2.25B | 1.42B | 1.18B | (996M) | (1.22B) |
| Pre-Tax Margin | 26.3% | 14.7% | 10.8% | -9.7% | -12.8% |
| Income Tax Expense | 330M | (489M) | (790M) | 510M | (90M) |
| Net Income | 1.89B | 1.89B | 1.96B | (1.52B) | (1.17B) |
| Net Margin | 22.1% | 19.6% | 17.9% | -14.8% | -12.2% |
| EPS (Basic) | 16.99 | 17.48 | 18.01 | (13.93) | (10.64) |
| EPS (Diluted) | 16.86 | 17.34 | 17.92 | (13.93) | (10.64) |
| Weighted Avg Shares | 111.22M | 108.38M | 108.85M | 109.27M | 109.5M |
| Weighted Avg Shares (Diluted) | 112.08M | 109.24M | 109.38M | 109.27M | 109.5M |
Celanese Corporation
NYSE:CE
Intrinsic Alpha fair value
Locked
Current Price
$48.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.